Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide

Myeloproliferative neoplasms and myelodysplastic syndrome

Myeloproliferative neoplasms (MPN) and myelodysplastic syndrome (MDS)

Important hematological malignancies to consider include myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). MDS and MPN are cancers that impact the volume of certain types of blood cells.

MPN

Quest Diagnostics MPN Diagnostic Cascading Reflex looks at genetic mutations to provide physicians a more accurate diagnostic workup for patients suspected of having myeloproliferative neoplasms.

MDS

LeukoVantage® is designed to aid in diagnosis, prognosis, and/or treatment strategy for patients with myelodysplastic syndrome using next-generation sequencing (NGS).  


This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.